| Characteristic | HIV-, N = 161 | HIV+ART+, N = 481 | p-value2 |
|---|---|---|---|
| cotrimoxazole | 0.4 | ||
| Susceptible | 3 (19%) | 5 (11%) | |
| non-susceptible | 13 (81%) | 42 (89%) | |
| Unknown | 0 | 1 | |
| tetracycline | 0.2 | ||
| Susceptible | 7 (44%) | 29 (60%) | |
| non-susceptible | 9 (56%) | 19 (40%) | |
| oxacillin | 0.3 | ||
| Susceptible | 10 (62%) | 26 (54%) | |
| Intermediate | 3 (19%) | 17 (35%) | |
| Resistant | 3 (19%) | 5 (10%) | |
| chloramphenicol | 0.2 | ||
| Susceptible | 15 (94%) | 48 (100%) | |
| non-susceptible | 1 (6.2%) | 0 (0%) | |
| erythromycin | 0.6 | ||
| Susceptible | 10 (62%) | 33 (70%) | |
| non-susceptible | 6 (38%) | 14 (30%) | |
| Unknown | 0 | 1 | |
| age | 30 (27, 33) | 33 (26, 40) | 0.4 |
| Unknown | 3 | 3 | |
| sex | 0.7 | ||
| Male | 4 (29%) | 11 (24%) | |
| Female | 10 (71%) | 34 (76%) | |
| Unknown | 2 | 3 | |
| MDR | 0.5 | ||
| non | 10 (62%) | 34 (71%) | |
| MDR | 6 (38%) | 14 (29%) | |
|
1
n (%); Median (IQR)
2
Fisher's exact test; Pearson's Chi-squared test; Wilcoxon rank sum test
|
|||